Study of the genetic variability in a Parkinson's Disease gene: EIF4G1
- PMID: 22561553
- PMCID: PMC3769807
- DOI: 10.1016/j.neulet.2012.04.033
Study of the genetic variability in a Parkinson's Disease gene: EIF4G1
Abstract
Chartier-Harlin and colleagues [2] recently reported mutations in the eukaryotic translation initiation factor 4-gamma (EIF4G1) gene in families with parkinsonism. Large-scale screening found two mutations (p.R1205H and p.A502V) only in affected individuals, although their relative frequency was very low. The aim of this study was to investigate EIF4G1 parkinsonism-related variants in two separate cohorts and study coding variability across the gene. We first screened a series of familial Parkinson's Disease (PD) patients in an attempt to confirm previous results by showing segregation. Then, to determine the extent of coding variation in the gene, we first screened a cohort of sub-Saharan African individuals from the Centre d'Etude du Polymorphisme Humain - Human Genome Diversity Cell Line Panel (HGDP) [1] and then analyzed data from 5350 individuals National Heart, Lung, and Blood Institute (NHLBI) exome sequencing project. We failed to identify any PD-related mutations in the familial samples. Conversely we found the p.A502V variant in the NHLBI population. We observed a high number of coding polymorphism in the exons where the two PD variants have been previously reported. We conclude that either EIF4G1 variants are an extremely rare cause of familial PD in Caucasian cohorts, or that A502V is in fact a rare benign variant not involved in PD aetiology. Our data also suggests that the protein can tolerate some extent of variability particularly at this point of the gene.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
EIF4G1 in familial Parkinson's disease: pathogenic mutations or rare benign variants?Neurobiol Aging. 2012 Sep;33(9):2233.e1-2233.e5. doi: 10.1016/j.neurobiolaging.2012.05.006. Epub 2012 Jun 1. Neurobiol Aging. 2012. PMID: 22658323
-
EIF4G1 is neither a strong nor a common risk factor for Parkinson's disease: evidence from large European cohorts.J Med Genet. 2015 Jan;52(1):37-41. doi: 10.1136/jmedgenet-2014-102570. Epub 2014 Nov 3. J Med Genet. 2015. PMID: 25368108
-
EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population.Parkinsonism Relat Disord. 2014 Jun;20(6):659-61. doi: 10.1016/j.parkreldis.2014.03.004. Epub 2014 Mar 18. Parkinsonism Relat Disord. 2014. PMID: 24704100 Free PMC article.
-
The EIF4G1 gene and Parkinson's disease.Acta Neurol Scand. 2015 Aug;132(2):73-8. doi: 10.1111/ane.12397. Epub 2015 Mar 13. Acta Neurol Scand. 2015. PMID: 25765080 Review.
-
The genetic landscape of Parkinson's disease.Rev Neurol (Paris). 2018 Nov;174(9):628-643. doi: 10.1016/j.neurol.2018.08.004. Epub 2018 Sep 21. Rev Neurol (Paris). 2018. PMID: 30245141 Review.
Cited by
-
Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease.Neurology. 2013 Mar 12;80(11):982-9. doi: 10.1212/WNL.0b013e31828727d4. Epub 2013 Feb 13. Neurology. 2013. PMID: 23408866 Free PMC article.
-
EIF4G1 mutations do not cause Parkinson's disease.Neurobiol Aging. 2015 Aug;36(8):2444.e1-4. doi: 10.1016/j.neurobiolaging.2015.04.017. Epub 2015 May 9. Neurobiol Aging. 2015. PMID: 26022768 Free PMC article.
-
Recent advances in Parkinson’s disease genetics.J Neurol. 2014 Feb;261(2):259-66. doi: 10.1007/s00415-013-7003-2. J Neurol. 2014. PMID: 23798000 Review.
-
Molecular _targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson's disease.Transl Neurodegener. 2019 Feb 4;8:6. doi: 10.1186/s40035-019-0145-0. eCollection 2019. Transl Neurodegener. 2019. PMID: 30740222 Free PMC article. Review.
-
Sequence variants in eukaryotic translation initiation factor 4-gamma (eIF4G1) are associated with Lewy body dementia.Acta Neuropathol. 2013 Mar;125(3):425-38. doi: 10.1007/s00401-012-1059-4. Epub 2012 Nov 4. Acta Neuropathol. 2013. PMID: 23124435 Free PMC article.
References
-
- Cann H.M., de Toma C., Cazes L., Legrand M.F., Morel V., Piouffre L., Bodmer J., Bodmer W.F., Bonne-Tamir B., Cambon-Thomsen A., Chen Z., Chu J., Carcassi C., Contu L., Du R., Excoffier L., Ferrara G.B., Friedlaender J.S., Groot H., Gurwitz D., Jenkins T., Herrera R.J., Huang X., Kidd J., Kidd K.K., Langaney A., Lin A.A., Mehdi S.Q., Parham P., Piazza A., Pistillo M.P., Qian Y., Shu Q., Xu J., Zhu S., Weber J.L., Greely H.T., Feldman M.W., Thomas G., Dausset J., Cavalli-Sforza L.L. A human genome diversity cell line panel. Science. 2002;296:261–262. - PubMed
-
- Chartier-Harlin M.C., Dachsel J.C., Vilariño-Güell C., Lincoln S.J., Leprêtre F., Hulihan M.M., Kachergus J., Milnerwood A.J., Tapia L., Song M.S., Le Rhun E., Mutez E., Larvor L., Duflot A., Vanbesien-Mailliot C., Kreisler A., Ross O.A., Nishioka K., Soto-Ortolaza A.I., Cobb S.A., Melrose H.L., Behrouz B., Keeling B.H., Bacon J.A., Hentati E., Williams L., Yanagiya A., Sonenberg N., Lockhart P.J., Zubair A.C., Uitti R.J., Aasly J.O., Krygowska-Wajs A., Opala G., Wszolek Z.K., Frigerio R., Maraganore D.M., Gosal D., Lynch T., Hutchinson M., Bentivoglio A.R., Valente E.M., Nichols W.C., Pankratz N., Foroud T., Gibson R.A., Hentati F., Dickson D.W., Destée A., Farrer M.J. Translation initiator EIF4G1 mutations in familial Parkinson Disease. American Journal of Human Genetics. 2011;89:398–406. - PMC - PubMed
-
- Khan N.L., Jain S., Lynch J.M., Pavese N., Abou-Sleiman P., Holton J.L., Healy D.G., Gilks W.P., Sweeney M.G., Ganguly M., Gibbons V., Gandhi S., Vaughan J., Eunson L.H., Katzenschlager R., Gayton J., Lennox G., Revesz T., Nicholl D., Bhatia K.P., Quinn N., Brooks D., Lees A.J., Davis M.B., Piccini P., Singleton A.B., Wood N.W. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain. 2005;128:2786–2796. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical